![Robert Ross](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Ross
Directeur/Bestuurslid bij
XILIO THERAPEUTICS, INC.
Vermogen: - $ op 31-08-2026
Profiel
Robert W.
Ross is currently Chief Executive Officer at Clasp Therapeutics, Inc. since 2023.
Dr. Ross serves as Independent Director at Xilio Therapeutics, Inc. since 2022.
Dr. Ross is Director at Obsidian Therapeutics, Inc. since 2020 and again starting 2026.
Formerly, Dr. Ross was President, Chief Executive Officer & Director at Surface Oncology, Inc. from 2021 to 2023.
Dr. Ross was SVP-Clinical Development & Pharmacovigilance at Genetix Biotherapeutics, Inc. from 2015 to 2016.
Education includes undergraduate studies at Stanford University, graduate degrees from Harvard Medical School, and Columbia University College of Physicians & Surgeons.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-06-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
Actieve functies van Robert Ross
| Bedrijven | Functie | Begin |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Directeur/Bestuurslid | 16-06-2022 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Directeur/Bestuurslid | 03-09-2020 |
ManaT Bio, Inc.
 ManaT Bio, Inc. Pharmaceuticals: MajorHealth Technology Specializes in discovery, development and delivery of immunotherapies | Algemeen Directeur | 01-11-2023 |
Eerdere bekende functies van Robert Ross
| Bedrijven | Functie | Einde |
|---|---|---|
| SURFACE ONCOLOGY, INC. | Algemeen Directeur | 01-09-2023 |
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01-10-2016 |
Opleiding van Robert Ross
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
60
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
ManaT Bio, Inc.
ManaT Bio, Inc. Pharmaceuticals: MajorHealth Technology Specializes in discovery, development and delivery of immunotherapies | Health Technology |
